Intro Widget
The International Journal of Gynecological Cancer (IJGC) is the primary educational and informational publication for topics relevant to detection, prevention, diagnosis, and treatment of gynecologic malignancies. Its content is read by gynecologists, medical oncologists, radiation oncologists, radiologists, pathologists, and research scientists with a special interest in gynecological oncology. IJGC emphasizes a multidisciplinary approach and includes original research, reviews, and video articles.
IJGC is the official journal of the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.
IJGC is a Plan S compliant Transformative Journal.
EDITOR-IN-CHIEF
Pedro Ramirez, MD, University of Texas MD Anderson Cancer Center
Editorial Board
Listen to the IJGC weekly podcast. Subscribe in all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify.
- Impact Factor
- 2.095
Highlighted Articles
Highlighted Articles
Twitter Feed
#Editorial
"Beyond oncologic outcomes: fertility & ovarian preservation as key priorities" @falconer_henrik @RParejaGineOnco & Dr. Gloria Salvo
https://t.co/PDRqK1ROML
@ESGO_society @IGCSociety @IJGCfellows @pedroramirezMD @HsuMd #GYNonc #GYNcancer #Fertility #Pregnancy #gyncsm
What's the most common 2nd #cancer in long-term #ovariancancer survivors? 2nd cancers more from screening or self-detection? Median duration btw dx of OC to 2nd cancer? Check➡️ https://t.co/A2saiEc2fM @HsuMd @agz_eriksson @pedroramirezMD @ChariteBerlin @OncoAlert @ESGO_society https://t.co/F5jY9pRjxY
March special issue 📄
Preservation of #fertility & hormonal function in #GYNcancer
#FellowsChoice w @DrAnnaCol1 & @NicoloBizzarri 👇 https://t.co/knPCS9Yw6v
@pedroramirezMD @ESGO_society @IGCSociety @GynMe4 @IJGCfellows @ENYGO_official @RParejaGineOnco @falconer_henrik #cancer https://t.co/F9gzzCAtkA
>85% #Cervicalcancer are in low-&middle- income countries.Clinical trials are limited in #lmic.CCRN is dedicated to expanding new opportunities. Check opportunity, here, now! → https://t.co/6MOWRsAL2K
@ENYGO_official @aagonco @PARSGO_Official
https://t.co/ywyjSnODgn https://t.co/3nCBPslwyF
Arthur_HC_Hsu
@HsuMd
>85% #Cervicalcancer are in low-&middle- income countries.Clinical trials are limited in #lmic.CCRN is dedicated to expanding new opportunities in such areas. What is CCRN? Check opportunity, here, now! → https://t.co/AOatPelrcQ
@IGCSociety @ESGO_society @ijgconline @oncoalert https://t.co/8V4peS0co6
>85% #Cervicalcancer are in low-&middle- income countries.Clinical trials are limited in #lmic.CCRN is dedicated to expanding new opportunities in such areas. What is CCRN? Check opportunity, here, now! → https://t.co/AOatPelrcQ
@IGCSociety @ESGO_society @ijgconline @oncoalert https://t.co/8V4peS0co6
How do you treat plat. sens. recurrent #ovariancancer? Would + ICI. improve the results of previous NOVA trial? Check trial protocol of ANITA by Antonio Gonzalez Martin. ➡️ https://t.co/CLO2IIwx3D
@IGCSociety @pedroramirezMD @agz_eriksson @ENYGO_official @ESGO_society #gynonc https://t.co/opPaWHShwb
